Heritas Capital Management is proud to announce that it has been appointed as a co-investment partner with SPRING SEEDS Capital (SSC), the investment arm of SPRING Singapore, under the Startup SG Equity scheme. Startup SG Equity is an initiative under Startup SG, which offers a holistic range of support for start-ups across all developmental stages. Partners were selected based on their expertise in the key sectors and their ability to add value to the start-ups.
“Heritas’ investment focus includes biotech, medtech, diagnostics and digital health sectors, addressing huge unmet needs and growth opportunities in chronic disease management; precision and personalised medicine; aging and wellness etc. We look forward to partnering SPRING Singapore and SPRING SEEDS Capital in catalysing promising healthcare and biomedical ventures through a hands-on and customised approach in providing funding, mentorship and access to business networks,” said Mr. Chik Wai Chiew, CEO and Executive Director of Heritas Capital Management.
Heritas is a CMS licensed A/I (Accredited and/or Institutional) fund management company with assets under management of over S$250 million. Heritas manages private equity and venture capital funds focused on healthcare, education and technology sectors across the Asia-Pacific region.